Examples of Reverted Compound in a sentence
For clarity, the licenses granted in Section 11.5 by BMS to Exelixis do not give Exelixis any right or license (a) to incorporate into any Product (e.g., as a combination product) any compound that is Controlled by Exelixis and that is not a Reverted Compound or (b) to perform any research that is directed to identifying, characterizing, developing or otherwise pursuing any small molecule compound that is not a Reverted Compound.
Agios and, subject to Sections 15.4(b) and 15.4(c), its Affiliates shall not, and shall not grant any Third Party the right to, Develop, Manufacture and/or Commercialize any Licensed Compound, Licensed Product, Celgene Reverted Compound or Celgene Reverted Product for any purpose, other than in connection with a Licensed Program or Celgene Reverted Program pursuant to the Collaboration under this Agreement.
Notwithstanding any exclusive license granted to PTI, Astellas will retain the right to use Collaboration Technology that Covers a Discontinued Compound, Reverted Compound or Reverted Product for its internal research purposes.
Ex. 5.14 Marks 10.7 Maxygen Indemnitees 12.5.1 (b) Maxygen Independent Inventions 10.2.2 (a) Maxygen Xxxx 5.2.7 Maxygen Opt-Out Right 4.1.4 (b) Maxygen Reverted Compound Activities 13.4.2(e)(vii) Maxygen-Selected New Compounds 13.4.2 (e)(v) Milestone Fin.
Notwithstanding anything to the contrary in Section 8.6(b) (Astellas’s Rights), if PTI is researching, Developing or Commercializing a Reverted Compound or Reverted Product, then PTI will have the exclusive right to initiate an Infringement Action anywhere in the Reverted Territory against any Third CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”.
Each Party shall provide the same level of disclosure to its in-house counsel concerning suspected infringement of a Reverted Compound Patent as such Party would provide with respect to suspected infringement of its own issued Patent or an exclusively licensed issued Patent claiming a product it is developing or commercializing independent of this Agreement.
In the event that management or in-house counsel for either Party becomes aware of a suspected infringement of a Patent that claims a Joint Invention but is not a Joint Product Patent or a Reverted Compound Patent (for purposes of this Section 8.4(c) only, an “Other Joint Patent”), such Party shall notify the other Party promptly, and following such notification, the Parties shall confer.
Confidential Party as to any Competing Infringement of any PTI Technology or Collaboration Technology related to such Reverted Compound or Reverted Product, at its sole cost and expense; provided, however, that PTI will not have the right to initiate an Infringement Action asserting any Multi-Product Patent Right without Astellas’s prior written consent, which consent will not be unreasonably withheld, conditioned, or delayed.
No settlement of any such action or defense which restricts the scope or affects the enforceability of a Reverted Compound Patent may be entered into by BMS without the prior consent of Exelixis (such consent to not be unreasonably withheld, delayed or conditioned).
No settlement of any such action or defense which restricts the scope or affects the enforceability of a Reverted Compound Patent may be entered into by Exelixis without the prior consent of BMS (such consent to not be unreasonably withheld, delayed or conditioned).